AI Funding Surge Masks Sector Consolidation Pressure
OVERVIEW VC funding remains elevated but increasingly bifurcated: AI-adjacent companies command premium valuations and mega-rounds, while traditional B2B and consumer plays struggle for attention. The gap between Series A funding for AI versus non-AI has widened to 3.5x, signaling structural market reallocation rather than healthy recovery. KEY SIGNALS Dry powder sits at $310B+ but deployment velocity favors proven teams with AI defensibility. Secondary market activity suggests LPs are rotating out of mid-stage generalist funds. Geographic dispersion is reversing: capital reconcentrating in SF/NYC/Boston with emerging pockets in DC (defense tech) and Boston (biotech). WHAT TO WATCH Monitor Q1 fund closures among mid-market generalists—several strategic repositionings announced quietly. Track downstream effects: the Series B crunch is intensifying for non-AI companies, creating M&A opportunities for strategic acquirers. Portfolio companies without AI pivot narratives face extended fundraising timelines and potential down-rounds.
This is a members-only intelligence brief from Yesodi. Join to read the full analysis, discuss with community members, and access all briefs.
Join Yesodi →